Skip to content

SG&A at other companies

MYR Group logo
MYR GroupMYRG
$69.42M+11.0%
Repligen logo
RepligenRGEN
$76.54M+8.2%
Griffon logo
GriffonGFF
$104.64M-2.6%
Power Integrations logo
Power IntegrationsPOWI
$24.44M-10.9%
Bausch Health Companies logo
Bausch Health CompaniesBHC
$861M-0.7%
Helmerich & Payne logo
Helmerich & PayneHP
$71.08M-12.0%

Other financials

Income statement

See full
Revenue$81.4M-6.1%
Gross profit$45.8M-13.9%
Operating income$10.0M-40.5%
Net income$4.2M+81.6%
EPS (diluted)$0.07+75.0%

Balance sheet

See full
Cash & equivalents$146.0M+50.4%
Total debt$11.1M-6.7%
Total equity$335.5M+12.0%
Total assets$893.2M+5.3%

Cash flow

See full
Operating cash flow$4.0M-42.0%
CapEx$2.1M+29.6%
Free cash flow$1.9M-64.2%

Valuation

See full
Market cap$2.47B+46.9%
P/E67.3×+0.2×
P/S6.1×+1.4×

Profitability

See full
Gross margin59%+4.4pp
Operating margin19.1%+5.6pp
Net margin9.1%+2.1pp
FCF margin28.5%+6.3pp

Returns & leverage

See full
Return on equity11.6%+2.6pp
Debt / equity0.0×

Where this comes from

Reported directly by Imax in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Imax’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Imax's sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Imax's SG&A?
Imax (IMAX) reported SG&A of $32.49M in Q1 2026.
How has Imax's SG&A changed year-over-year?
Imax's SG&A decreased by 2.9% year-over-year, from $33.46M to $32.49M.
What is the long-term trend for Imax's SG&A?
Over 3 years (2022 to 2025), Imax's SG&A has grown at a 0.1% compound annual growth rate (CAGR), from $138.04M to $138.46M.
What does SG&A mean?
Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.